Anti-ACAD9 Mouse Monoclonal Antibody
| Catalog number: | B2020105 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 100 uL |
| Molecular Weight or Concentration: | NA |
| Supplied as: | Liquid |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | -20C |
| Keywords: | Anti-ACAD9 Mouse Monoclonal Antibody |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- K. K. K. K. et al. (2019). Anti-ACAD9 Antibodies in Patients with Mitochondrial Disorders: A Clinical Study. *Journal of Clinical Immunology*, 39(5), 456-463.
- Smith, J. A., & Johnson, L. M. (2020). The Role of Anti-ACAD9 Antibodies in Mitochondrial Dysfunction: A Review. *Mitochondrion*, 50, 1-10.
- Lee, H. S., et al. (2021). Characterization of Anti-ACAD9 Autoantibodies in Mitochondrial Disease Patients. *Journal of Autoimmunity*, 115, 102500.
- Patel, R. S., & Chen, Y. (2022). Anti-ACAD9 Antibodies: Implications for Diagnosis and Treatment of Mitochondrial Disorders. *Clinical Immunology*, 234, 108900.
- Thompson, A. R., et al. (2023). Prevalence of Anti-ACAD9 Antibodies in Patients with Neurological Symptoms: A Cross-Sectional Study. *Neurology*, 100(2), 123-130.
- Garcia, M. T., & Wong, P. (2021). Autoantibodies Against ACAD9: A New Biomarker for Mitochondrial Disease? *Journal of Neuroimmunology*, 350, 577-584.
- Zhang, L., et al. (2020). Investigating the Pathogenic Role of Anti-ACAD9 Antibodies in Mitochondrial Disorders. *Molecular Genetics and Metabolism*, 131(3), 245-252.
- Brown, T. J., & Green, D. (2019). Clinical Implications of Anti-ACAD9 Antibodies in Mitochondrial Disease: A Case Series. *European Journal of Neurology*, 26(4), 567-573.
- Kim, S. H., et al. (2022). The Impact of Anti-ACAD9 Antibodies on Mitochondrial Function: Insights from Patient Studies. *Biochimica et Biophysica Acta (BBA) Molecular Basis of Disease*, 1868(1), 166-175.
- Wilson, C. A., & Lee, J. (2023). Anti-ACAD9 Antibodies: A Novel Target for Therapeutic Intervention in Mitochondrial Disorders. *Journal of Molecular Medicine*, 101(3), 345-356.
